Entrepreneurial Lead of the NuclearMediX team and Postdoctoral Researcher at Imperial College London. Dr. Fu has extensive experience in drug development, from lead selection to pre-clinical stages. He specializes in developing and managing novel radioconjugates of small molecules, peptides, and antibodies.
Dr. Ruisi Fu
